****EVENT DRIVEN TRADERS' BOARD****

[funnyG986]

ENZB divi spin off + NYSE co buy co the spin off company
https://www.sec.gov/Archives/edgar/data/1471968/000147196817000001/dividend8k.htm

Each common and preferred shareholder will receive one (1) share, par value $0.001, of Shareholder Acquisition Corp. common or preferred stock for each eight hundred (800) shares of EnzymeBioSystems common and preferred stock currently owned. Any fractional share(s) will be rounded to the nearest whole share.

Purpose of the Dividend Spin-off

EnzymeBioSystems has made arrangements with Her Imports, formerly known as EZJR, Inc., a Nevada corporation, to acquire Shareholder Acquisition Corp., following the dividend spin-off. Once acquired as a wholly owned subsidiary of Her Imports, common shares of Her Imports will be exchanged for shares of Shareholder Acquisition Corp., on a pro-rata basis. After the exchange takes place, the subsidiary will be collapsed into Her Imports. In order to help facilitate the transition of Shareholder Acquisition Corp into Her Imports, the sole officer of Shareholder Acquisition Corp., Barry Hall is the Chief Executive Officer of Her Imports. In December 2016, Her Imports announced that it was working to obtain a listing on the NYSE MKT exchange. Her Imports desires to acquire this spin-off, in order to help Her Imports increase its shareholder base, in order to assist Her Imports to qualify for the NYSE MKT listing requirements.

Dividend Record and Payment Date

EnzymeBioSystems established January 30, 2017 as the dividend record date; and, FINRA will establish the final payment date. Each shareholder will receive a dividend of one share of common, par value $0.001 or preferred, par value $0.001, for each eight hundred (800) shares of EnzymeBioSystems common and preferred stock currently owned on the record date.

As of January 17, 2017, EnzymeBioSystems has 16,641,822 common shares issued and outstanding and 2,500,000 voting preferred shares issued and outstanding prior to the spin-off dividend; and, as a result the spin-off stock dividend, Shareholder Acquisition Corp. will have approximately 21,000 common shares and 3,125 preferred “like kind” shares issued and outstanding following the dividend. After the issuance of the spin-off dividend, Shareholder Acquisition Corp. will no longer be part of EnzymeBioSystems.